| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |